<DOC>
	<DOCNO>NCT00280657</DOCNO>
	<brief_summary>The purpose study determine safety efficacy oral contraceptive treat acne papulopustulosa .</brief_summary>
	<brief_title>Study Safety Efficacy Oral Contraceptive Treating Acne Papulopustulosa</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Patients mild moderate facial papulopustular acne Contraindication use hormonal contraceptive</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Acne papulopustulosa</keyword>
</DOC>